Pursuant to Regulation 30(6) of the SEBI Listing Regulations, Biocon has informed that the meeting was conducted with the Institutional Investors / Research Analysts ‘Nalanda Capital’ & ‘BofA Securities’ on 11th December, 2024 on 1x1 / In-person basis in Bengaluru.
The above information is a part of company’s filings submitted to BSE.